TMS for Social Anxiety
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, can help researchers understand the brain circuits involved in social motivation. The study focuses on adults with depression or social anxiety who often avoid social situations. Participants will attend several sessions involving TMS and MRI scans to gather data. Individuals living in the Auburn/Opelika area who struggle with social interactions due to depression or social anxiety may be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new insights and treatments for social anxiety and depression.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but your medication regimen must be stable, meaning no changes in medication or dosage in the past 3 months.
What prior data suggests that TMS is safe for social anxiety?
Research has shown that transcranial magnetic stimulation (TMS) is generally safe. Studies have found that it can significantly reduce anxiety by targeting specific brain areas related to mood and fear. Modern research indicates a very low risk of serious side effects, such as seizures—less than 0.1%. Most people tolerate it well.
Those who have undergone TMS typically do not report major issues. Some may experience mild side effects, like headaches or discomfort at the treatment site, but these usually resolve quickly. Overall, based on past research, TMS is considered a safe option for individuals with social anxiety.12345Why are researchers excited about this trial?
Researchers are excited about TMS (transcranial magnetic stimulation) for social anxiety because it offers a non-invasive option that targets the brain directly. Unlike traditional treatments such as cognitive-behavioral therapy and medications like SSRIs, TMS uses magnetic fields to stimulate nerve cells in the brain, potentially providing relief more quickly and with fewer side effects. This treatment specifically focuses on the right dorsolateral prefrontal cortex, a region associated with mood regulation, which could make it a promising alternative for those who haven't responded well to other therapies.
What evidence suggests that TMS could be an effective treatment for social anxiety?
This trial will compare two approaches: active transcranial magnetic stimulation (TMS) and sham TMS. Studies have shown that TMS can effectively reduce symptoms of social anxiety. In one study, patients saw their anxiety symptoms decrease by over 70% after treatment. Another study found that about half of the patients experienced a significant reduction in anxiety, and about 30% had their symptoms mostly disappear. Research suggests that TMS targets specific brain areas involved in mood and fear, aiding in better anxiety management. Overall, evidence indicates that TMS is a promising option for those dealing with social anxiety.12346
Are You a Good Fit for This Trial?
This trial is for adults aged 25-50 in the Auburn/Opelika area who avoid social situations and have been diagnosed with either major depression or social anxiety disorder. Participants must show significant social avoidance on a screening test.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo four study visits involving surveys, clinical interviews, computer tasks, MRI scans, and TMS sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- TMS
Trial Overview
The study uses transcranial magnetic stimulation (TMS) to explore how brain circuits are involved in social motivation. Participants attend four visits over about one month, including surveys, MRI scans, computer tasks, and TMS sessions.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Active continuous thetaburst stimulation administered over right dorsolateral prefrontal cortex for 40 seconds (600 pulses total)
Sham continuous thetaburst stimulation administered over right dorsolateral prefrontal cortex for 40 seconds (600 pulses total)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Auburn University
Lead Sponsor
Citations
Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat ...
Two and four weeks after rTMS treatment and after 2 weeks follow-up, patient showed large reduction in social anxiety symptoms (areas most highly rated on LSAS; ...
2.
frontiersin.org
frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2024.1373564/fullTackling social anxiety with targeted brain stimulation
The results suggest that tSMS may suppress overactivity in rFPA, reduce SFA to body sensation, and increase adaptive attention in highly socially anxious ...
Reduction of social anxiety symptoms with transcranial direct ...
There was a 51% reduction in the LSAS score and 39% in the SPIN after the 5 days of intervention, and in the 15-day follow-up, a 71% reduction ...
Efficacy and acceptability of brain stimulation for anxiety ...
The study results suggest that BSTs are effective treatments for anxiety disorders, OCD and PTSD; lf-rTMS may be considered as the most promising option.
Benefits of Transcranial Magnetic Stimulation for Anxiety
Research shows that approximately 50% of patients experience reductions in anxiety symptoms after TMS treatment, with about 30% achieving remission. TMS ...
Tackling social anxiety with targeted brain stimulation - PMC
The results suggest that tSMS may suppress overactivity in rFPA, reduce SFA to body sensation, and increase adaptive attention in highly socially anxious ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.